What is Merck gaining by supplying free STD vaccines to China? We all know that vaccine companies are unscrupulous when it comes to making money, so there is certainly more to this story than just benevolence in the interest of public health. As admitted by WA Today, China appears to be allowing U.S. drug companies vauable access to the growing Chinese consumer market in exchange for vaccine rights. Shenzhen currently holds a 60 percent market share on hepatitis B vaccine production in China, with a soon-to-be developed, multi-million dollar research, development, and manufacturing center set to be built in the city of Shenzhen. This facility will presumably manufacture more hepatitis B vaccines that, according to The New York Times (NYT), contains genetically-modified (GM) ingredients. Buried deep within the NYT archives is an article explaining that in exchange for the free hepatitis B vaccine, Merck received special payments to help fund plant start-ups and training. In other words, Merck did receive kickbacks in exchange for providing China with a toxic vaccine that is poisoning and killing its babies.
Posted on: Wed, 10 Dec 2014 12:06:26 +0000
Trending Topics
Recently Viewed Topics
© 2015